Molnupiravir shows itself to be antiviral treatment for COVID-19. This newly developed drug targets the replication of the SARS-CoV-2 virus, seeking to lessen the severity of symptoms. Clinical trials indicate that https://www.milanmedicals.com/molnupiravir-200-mg